Naturally Selected Rilpivirine-Resistant HIV-1 Variants by Host Cellular Immunity-Reference-Cited by-同舟云学术

Naturally Selected Rilpivirine-Resistant HIV-1 Variants by Host Cellular Immunity

Published:2013-06-23 Issue:7 Volume:57 Page:1051-1055
ISSN:1537-6591
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Gatanaga Hiroyuki,Murakoshi Hayato,Hachiya Atsuko,Hayashida Tsunefusa,Chikata Takayuki,Ode Hirotaka,Tsuchiya Kiyoto,Sugiura Wataru,Takiguchi Masafumi,Oka Shinichi

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/57/7/1051/17853392/cit430.pdf

Reference25 articles.

1. Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naïve adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial;Molina;Lancet,2011

2. Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naïve adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial;Cohen;Lancet,2011

3. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents.;Department of Health and Human Services Panel on Antiretroviral Guidelines for Adult and Adolescents

4. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society–USA panel;Thompson;JAMA,2012

5. Update of the drug resistance mutations in HIV-1: March 2013;Johnson;Top Antivir Med,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-acting antiretroviral therapy effectiveness and patient satisfaction using patient questionnaires: data from a real-world setting;2024-03-06

2. Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use;Journal of Antimicrobial Chemotherapy;2023-08-16

3. HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells;Cancers;2022-12-30

4. High Level of Pre-Treatment HIV-1 Drug Resistance and Its Association with HLA Class I-Mediated Restriction in the Pumwani Sex Worker Cohort;Viruses;2022-01-28

5. Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link;eLife;2021-06-01